Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Yana Najjar
Condition: Advanced Melanoma, Unresectable Melanoma
NCT04493203
Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.